• About Meda
    • Meda in brief
    • Sales and Marketing
    • Business Development
    • Drug Development
      • Meda's Pipeline
    • Regulatory Affairs
    • Manufacture and Product Supply
    • Meda’s Sustainability Report 2010
    • Board of Directors
    • Senior Executives
  • Product Portfolio
    • Respiratory
    • Cardiology
    • Pain/Inflammation
    • CNS
    • Dermatology
    • Gastroenterology
    • OTC Products
    • Meda's Pipeline
      • Respiratory
      • Pain and Inflammation
      • Dermatology
      • CNS
      • Oncology
  • Financial information
    • Ownership Structure
    • Financial Reports
    • Annual Reports
    • Financial Calender
    • Corporate Governance
      • Annual General Meeting
      • Nomination Committee
      • Board of Directors
        • Audit Committee
      • Senior Executives
      • Auditors
      • Remuneration Principles
      • Share-related incentive programs
      • Financial Reporting
      • Articles of Association
  • News
  • Contact us
Print E-mail this page
  • About Meda
  • Product Portfolio
  • Financial information
  • News
  • Contact us
  • Sitemap »
  • Swedish | 
  • English
Meda Worldwide
  • Sweden
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Grece
  • Hungary
  • Ireland
  • Italy
  • Lituania
  • Latvia
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Serbia
  • Slovakia
  • Spain
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • USA

Meda AB
Box 906
SE-170 09 Solna
Sweden

Visitors: Pipers väg 2A
Tel: +46 8-630 19 00
Fax: +46 8-630 19 50
E-mail: info@meda.se

  • Contact »
  • Terms of Use »
  • Privacy Policy »
  • Cookies »
  • Copyright Meda »